crizotinib
PKU-2015052005
Approved small_molecule terminated
Quick answer
crizotinib for Systemic Anaplastic Large-Cell Lymphoma is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Systemic Anaplastic Large-Cell Lymphoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated